Kublaoui, B.M., Gemelli, T., Tolson, K.P., Wang, Y., and Zinn, A.R. 2008. Oxytocin deficiency mediates hyperphagic obesity of Sim1 haploinsufficient mice. Mol. Endocrinology. 7:1723-173. http://www.ncbi.nlm.nih.gov/pubmed/18451093?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum

Bingham, N.C., Anderson, K.E., Reuter, A.L., Stallings, N.R., and Parker, K.L. 2008. Selective loss of leptin receptors in the ventromedial hypothalamic nucleus results in increased adiposity and a metabolic syndrome. Endocrinology. 149(5):2138-2148. 
http://www.ncbi.nlm.nih.gov/pubmed/18258679?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum

 

Zhao, L., Kim. K-W, Ikeda. Y, Anderson. K.K., Beck, L., Chase, S., Tobet, S.A., and Parker, K.L. 2008. CNS-specific knockout of steroidogenic factor 1 results in increased anxiety-like behavior. Mol. Endocrinology. 6:1403-1415.

Yang, J., Brown, M.S., Liang, G. Grishin, N.V., and Goldstein, J.L. 2008. Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone.  Cell.  132:387-396.

http://www.ncbi.nlm.nih.gov/pubmed/18267071?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum

Inagaki, T., Dutchak, P., Zhao, G., Ding, X., Gautron, L., Parameswara, V., Li, Y., Goetz, R., Mohammadi, M., Esser, V., Elmquist, J.K., Gerard, R.D., Burgess, S.C., Hammer, R.E., Mangelsdorf, D.J., Kliewer, S.A. Endocrine regulation of the fasting response by PPARalpha-mediated induction of Fibroblast Growth Factor 21. Cell Metab. 2007 Jun;5(6):415-425.

http://www.ncbi.nlm.nih.gov/pubmed/17550777?ordinalpos=3&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum

Satapati, S., He, T., Inagaki, T., Potthoff, M,. Merritt ,M., Esser, V., Mangelsdorf, D.J., Kliewer, S.A., Browning, J.D., Burgess, S.C. 2008. Partial resistance to PPARa agonists in Zucker diabetic fatty (ZDF) rats is associated with impaired hepatic mitochondrial function. Diabetes.  In press.

http://www.ncbi.nlm.nih.gov/pubmed/18469201?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum

Romeo, S., Pennacchio, L.A., Fu, Y., Boerwinkle, E., Tybjaerg-Hansen, A. Hobbs, H.H., Cohen, J.C. 2007. Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL. Nat. Genet. 39(4):513-516.
http://www.ncbi.nlm.nih.gov/pubmed/17322881?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum

Lutter, M., Sakata, I., Osborne-Lawrence, S., Rovinsky, S.A., Anderson, J.G., Jung, S., Birnbaum, S., Yanagisawa, M., Elmquist, J.K., Nestler, E.J. and Zigman, J.Z. 2008. The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress.  Nature Neuroscience. 11(7):752-753.
http://www.ncbi.nlm.nih.gov/pubmed/18552842?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum

 

Inagaki, T., Lin, V.Y., Goetz, R., Mohammadi, M., Mangelsdorf, D. J., and Kliewer, S. A. 2008. Inhibition of growth hormone signaling by the fasting-induced hormone FGF2. Cell Metab. 8: 77-83.